WTW:NASDAQWillis Towers Watson Public Limited Company Analysis
Data as of 2026-05-11 - not real-time
$256.36
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Willis Towers Watson (WTW) is trading at $256.36, well under its 20‑day (≈$279.8), 50‑day (≈$287.0) and 200‑day (≈$315.4) moving averages, signaling a bearish technical backdrop. The 14‑day RSI sits at 31.7, placing the stock in oversold territory, while the MACD remains in a bearish configuration with a negative histogram. Volume has been increasing, providing some support for a potential short‑term bounce toward the identified support level around $246.6. However, the 30‑day realized volatility exceeds 42%, indicating that price swings may be wide and erratic.
Fundamentally, WTW delivers solid earnings with an 8.5% revenue growth year‑over‑year, healthy margins (gross 42%, operating 20%) and a 20.6% ROE, while its forward PE of 11.6 is well below the industry average of 16.4, suggesting the stock is undervalued. The DCF‑derived fair value of roughly $362 implies an upside of over 30% from current levels, and the dividend yield of 1.5% is backed by a modest 21.8% payout ratio, making the dividend sustainable. Analysts are broadly positive, with a consensus “Buy” rating, a median 12‑month target near $335, and recent upgrades from Citigroup, reinforced by high‑profile investor interest. Together, these fundamentals and sentiment outweigh the short‑term bearish technical signals.
Fundamentally, WTW delivers solid earnings with an 8.5% revenue growth year‑over‑year, healthy margins (gross 42%, operating 20%) and a 20.6% ROE, while its forward PE of 11.6 is well below the industry average of 16.4, suggesting the stock is undervalued. The DCF‑derived fair value of roughly $362 implies an upside of over 30% from current levels, and the dividend yield of 1.5% is backed by a modest 21.8% payout ratio, making the dividend sustainable. Analysts are broadly positive, with a consensus “Buy” rating, a median 12‑month target near $335, and recent upgrades from Citigroup, reinforced by high‑profile investor interest. Together, these fundamentals and sentiment outweigh the short‑term bearish technical signals.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Oversold RSI suggests potential near‑term bounce
- Price below key moving averages indicates bearish bias
- Increasing volume supports short‑term support level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant upside to DCF fair value
- Strong earnings growth and margins
- Positive analyst consensus and recent upgrades
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend with low payout ratio
- Stable cash flow and solid ROE
- Low beta indicating limited market‑wide volatility exposure
Key Metrics & Analysis
Financial Health
Revenue Growth8.50%
Profit Margin16.84%
P/E Ratio15.1
ROE20.61%
ROA5.09%
Debt/Equity85.69
P/B Ratio3.1
Op. Cash Flow$1.8B
Free Cash Flow$2.1B
Industry P/E16.4
Technical Analysis
TrendBearish
RSI31.7
Support$246.61
Resistance$300.98
MA 20$279.78
MA 50$287.00
MA 200$315.44
MACDBearish
VolumeIncreasing
Fear & Greed Index90.73
Valuation
Fair Value$361.59
Target Price$336.21
Upside/Downside31.15%
GradeUndervalued
TypeBlend
Dividend Yield1.50%
Risk Assessment
Beta0.07
Volatility42.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.